Immunocore Holdings plc (IMCR)
NASDAQ: IMCR · Real-Time Price · USD
28.55
-0.99 (-3.35%)
May 13, 2025, 4:00 PM - Market closed
Immunocore Holdings Employees
Immunocore Holdings had 493 employees as of December 31, 2024. The number of employees decreased by 4 or -0.80% compared to the previous year.
Employees
493
Change (1Y)
-4
Growth (1Y)
-0.80%
Revenue / Employee
$676,635
Profits / Employee
-$43,870
Market Cap
1.43B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
IMCR News
- 7 days ago - Immunocore reports first quarter financial results and provides a business update - GlobeNewsWire
- 5 weeks ago - Immunocore to present at upcoming investor conferences - GlobeNewsWire
- 2 months ago - Immunocore presents initial multiple ascending dose data for HIV functional cure candidate in an oral presentation at CROI 2025 - GlobeNewsWire
- 2 months ago - Immunocore: A Commercial Biotech Nearing Its Pivotal Break-Even Point - Seeking Alpha
- 2 months ago - Immunocore Holdings plc (IMCR) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Immunocore reports fourth quarter and full year 2024 financial results and provides a business update - GlobeNewsWire
- 2 months ago - Immunocore to report fourth quarter and full year 2024 financial results and host call on February 26, 2025 - GlobeNewsWire
- 4 months ago - Immunocore announces strategic priorities at 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire